1. Liu, L.; Ling, Y.; Havel, C.; Bashnick, L.; Young, W.; Rai, R.; Vijaykumar, D.; Riggs, J. R.; Ton, T.; Shaghafi, M.; Graupe, D.; Mordenti, J.; Sukbuntherng, J.Species comparison ofin vitroandin vivoconversion of fiveN-hydroxyamidine prodrugs of fVIIA inhibitors to their corresponding active amidines. Presented at the13th North America ISSX Meeting,Maui, HI,2005.
2. Lessons Learned from Marketed and Investigational Prodrugs
3. 455. The strength of heterocyclic bases
4. Metabolism-Directed Optimisation of Antithrombotics: The Prodrug Principle
5. Clement, B.Pharmaceutical preparations that contain an active substance with modified amidine groups. Patents DE 4321444, WO 9501168, EP 0708640, US 5786383, and JP 3838657,1995.